These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 16020268)
1. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Kaestel CG; Lovato P; Ødum N; Nissen MH; Röpke C Curr Eye Res; 2005 May; 30(5):375-83. PubMed ID: 16020268 [TBL] [Abstract][Full Text] [Related]
2. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation. Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586 [TBL] [Abstract][Full Text] [Related]
3. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289 [TBL] [Abstract][Full Text] [Related]
4. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Jørgensen A; Wiencke AK; la Cour M; Kaestel CG; Madsen HO; Hamann S; Lui GM; Scherfig E; Prause JU; Svejgaard A; Odum N; Nissen MH; Röpke C Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1590-9. PubMed ID: 9699548 [TBL] [Abstract][Full Text] [Related]
5. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Kaestel CG; Jørgensen A; Nielsen M; Eriksen KW; Ødum N; Holst Nissen M; Röpke C Exp Eye Res; 2002 May; 74(5):627-37. PubMed ID: 12076084 [TBL] [Abstract][Full Text] [Related]
6. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257 [TBL] [Abstract][Full Text] [Related]
7. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Yoshida M; Kezuka T; Streilein JW Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287 [TBL] [Abstract][Full Text] [Related]
8. Role and expression of CD40 on human retinal pigment epithelial cells. Willermain F; Caspers-Velu L; Baudson N; Dubois C; Hamdane M; Willems F; Velu T; Bruyns C Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3485-91. PubMed ID: 11006243 [TBL] [Abstract][Full Text] [Related]
9. Superantigen presentation by human retinal pigment epithelial cells to T cells is dependent on CD2-CD58 and CD18-CD54 molecule interactions. Jørgensen A; Junker N; Kaestel CG; Liang Y; Wiencke A; la Cour M; Lui GM; Ødum N; Nissen MH; Röpke C Exp Eye Res; 2001 Nov; 73(5):723-33. PubMed ID: 11747372 [TBL] [Abstract][Full Text] [Related]
10. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing. Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128 [TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458 [TBL] [Abstract][Full Text] [Related]
13. Thrombospondin plays a vital role in the immune privilege of the eye. Zamiri P; Masli S; Kitaichi N; Taylor AW; Streilein JW Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):908-19. PubMed ID: 15728547 [TBL] [Abstract][Full Text] [Related]
14. Activated retinitis pigmentosa peripheral lymphocytes adhere to and alter cultured human retinal pigment epithelial cells. Williams LL; Lew HM; Shannon BT; Singley CT; Chambers RB; Davidorf FH Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2848-60. PubMed ID: 1526734 [TBL] [Abstract][Full Text] [Related]
15. Human iris pigment epithelial cells suppress T-cell activation via direct cell contact. Hattori T; Kezuka T; Usui Y; Okunuki Y; Takeuchi M; Maruyama K; Haneda M; Shirato S; Goto H Exp Eye Res; 2009 Sep; 89(3):358-64. PubMed ID: 19379738 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycle. Matsui Y; Shapiro HM; Sheehy MJ; Christenson L; Staunton DE; Eynon EE; Yunis EJ Eur J Immunol; 1986 Mar; 16(3):248-51. PubMed ID: 3082649 [TBL] [Abstract][Full Text] [Related]
17. Surface markers on human activated T lymphocytes. IV. Comparison of high-affinity E-rosette receptor expression with the expression of other activation markers (receptor for interleukin 2, MHC class II (antigens). Kontny E; Ryzewska A Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):421-32. PubMed ID: 1718236 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. Xu L; Liu Y; He X Cell Mol Immunol; 2005 Aug; 2(4):295-300. PubMed ID: 16274628 [TBL] [Abstract][Full Text] [Related]